The role of αA-crystallin in experimental autoimmune uveitis

L. Wang, L. Zhang, Z. F. Wang, Z. X. Huang, X. Hu, L. Gong, X. Tang, F. Liu, Z. Luo, W. Ji, W. F. Hu, Z. Woodward, J. Zhu, Y. Z. Liu, Q. D. Nguyen, D. W.C. Li

Research output: Contribution to journalArticlepeer-review


Uveitis refers to a group of ocular inflammatory diseases that can lead to blindness. For years, researchers have been trying to decipher the underlying mechanisms and develop therapeutic strategies using the model of experimental autoimmune uveitis (EAU). Recently, αA-crystallin has been found to be upregulated in EAU and can even ameliorate its severity through different mechanisms, suggesting its use as a potent therapeutic factor against uveitis. Here we review the protective role of αA-crystallin and discuss its functional mechanisms in EAU.

Original languageEnglish (US)
Pages (from-to)558-564
Number of pages7
JournalCurrent Molecular Medicine
Issue number6
StatePublished - Aug 1 2015


  • Experimental autoimmune uveitis
  • Gene therapy
  • Uveitis
  • αA-crystallin

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'The role of αA-crystallin in experimental autoimmune uveitis'. Together they form a unique fingerprint.

Cite this